HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lily Hechtman Selected Research

Aftercare (After-Treatment)

8/2012Peer rejection and friendships in children with Attention-Deficit/Hyperactivity Disorder: contributions to long-term outcomes.
5/2009The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lily Hechtman Research Topics

Disease

70Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2022 - 05/2002
7Substance-Related Disorders (Drug Abuse)
01/2018 - 09/2003
5Learning Disabilities (Learning Disability)
07/2004 - 07/2004
3Oppositional Defiant Disorder
03/2011 - 01/2003
2Confusion (Bewilderment)
07/2008 - 07/2008
1Anxiety Disorders (Anxiety Disorder)
01/2022
1Bulimia Nervosa
04/2010
1Nausea
02/2007
1Headache (Headaches)
02/2007
1Anorexia
02/2007
1Sleep Initiation and Maintenance Disorders (Insomnia)
02/2007

Drug/Important Bio-Agent (IBA)

36Pemetrexed (MTA)FDA Link
01/2022 - 05/2002
12Methylphenidate (Ritalin)FDA LinkGeneric
09/2012 - 01/2003
3Dextroamphetamine (Dexedrine)FDA LinkGeneric
05/2014 - 04/2006
2CatecholaminesIBA
01/2020 - 01/2017
2Dopamine (Intropin)FDA LinkGeneric
01/2017 - 05/2014
2Amphetamine (Amfetamine)FDA LinkGeneric
05/2014 - 09/2012
2Paroxetine (Paxil)FDA LinkGeneric
03/2011 - 04/2006
1Flavin-Adenine Dinucleotide (FAD)IBA
01/2022
1Illicit Drugs (Recreational Drugs)IBA
01/2018
1trans-sodium crocetinate (crocetin)IBA
12/2015
1RacloprideIBA
05/2014
1LactoseFDA LinkGeneric
05/2014
1BuffersIBA
08/2012
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
10/2007
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
05/2006
1Aligeron (AS 2)IBA
01/2003

Therapy/Procedure

52Combined Modality Therapy
01/2022 - 05/2002
6Therapeutics
01/2020 - 07/2004
2Aftercare (After-Treatment)
08/2012 - 05/2009
1Drug Therapy (Chemotherapy)
01/2020
1Ambulatory Care (Outpatient Care)
02/2007